These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 18590011)

  • 21. Potential impact and cost-effectiveness analysis of rotavirus vaccination of children in Israel.
    Chodick G; Waisbourd-Zinman O; Shalev V; Kokia E; Rabinovich M; Ashkenazi S
    Eur J Public Health; 2009 Jun; 19(3):254-9. PubMed ID: 19221026
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Progress in introduction of pneumococcal conjugate vaccine--worldwide, 2000-2008.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2008 Oct; 57(42):1148-51. PubMed ID: 18946462
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cost-effectiveness of introducing the conjugated pneumococcal vaccine to routine free immunizations for infants in Lazio, Italy.
    Giorgi-Rossi P; Merito M; Borgia P
    Health Policy; 2009 Feb; 89(2):225-38. PubMed ID: 18639952
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of infant immunization programs with pneumococcal conjugate vaccine in Europe.
    Rose M; Zielen S
    Expert Rev Vaccines; 2009 Oct; 8(10):1351-64. PubMed ID: 19803758
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Cost- effectiveness analysis of pneumococcal vaccination in Iceland].
    Björnsdóttir M
    Laeknabladid; 2010 Sep; 96(9):537-43. PubMed ID: 20820070
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Is pneumococcal conjugate vaccine needed?].
    Nuorti P
    Duodecim; 2002; 118(1):77-9. PubMed ID: 12229003
    [No Abstract]   [Full Text] [Related]  

  • 27. [Splenectomy and pneumococcal vaccination].
    Postma MJ; Heijnen MA; de Vries R; Beutels P; Jager JC
    Ned Tijdschr Geneeskd; 2003 Jun; 147(23):1141-2; author reply 1142. PubMed ID: 12822527
    [No Abstract]   [Full Text] [Related]  

  • 28. [Cost-effectiveness of pneumococcal vaccination of the elderly].
    Hak E; Grobbee DE; Verheij TJ
    Ned Tijdschr Geneeskd; 1998 Jan; 142(4):201-2; author reply 202-3. PubMed ID: 9557028
    [No Abstract]   [Full Text] [Related]  

  • 29. Cost-benefit analysis of a rotavirus immunization program in the Arab Republic of Egypt.
    Ortega O; El-Sayed N; Sanders JW; Abd-Rabou Z; Antil L; Bresee J; Mansour A; Adib I; Nahkla I; Riddle MS
    J Infect Dis; 2009 Nov; 200 Suppl 1():S92-8. PubMed ID: 19817621
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Influenza vaccine and pneumococcal vaccine covered by health insurance].
    Eitrem R
    Lakartidningen; 1997 Sep; 94(36):3017. PubMed ID: 9312617
    [No Abstract]   [Full Text] [Related]  

  • 31. [Cost-effectiveness of pneumococcal vaccination in the elderly].
    van den Berg JW
    Ned Tijdschr Geneeskd; 1998 Jan; 142(4):202-3. PubMed ID: 9557029
    [No Abstract]   [Full Text] [Related]  

  • 32. Probabilistic cost-effectiveness analysis of the long-term effect of universal hepatitis B vaccination: an experience from Taiwan with high hepatitis B virus infection and Hepatitis B e Antigen positive prevalence.
    Hung HF; Chen TH
    Vaccine; 2009 Nov; 27(48):6770-6. PubMed ID: 19735755
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Vaccination: cost-effectiveness ratio].
    Swennen B
    Rev Med Brux; 2009 Sep; 30(4):451-7. PubMed ID: 19899394
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The economic cost of invasive pneumococcal disease and the potential for reduction by vaccination in an adult population in South Yorkshire.
    Parsons HK; Tomlin K; Metcalf SC; Brazier JE; Dockrell DH
    QJM; 2006 May; 99(5):348-9. PubMed ID: 16638754
    [No Abstract]   [Full Text] [Related]  

  • 35. Commentary on: Cost-effectiveness of pneumococcal vaccination and of programs to increase its uptake in U.S. older adults.
    Andrew MK
    J Am Geriatr Soc; 2024 Aug; 72(8):2299-2302. PubMed ID: 39007431
    [No Abstract]   [Full Text] [Related]  

  • 36. Preventing pneumococcal disease.
    Thomas R
    Can Fam Physician; 1998 Oct; 44():2180-1, 2184-5. PubMed ID: 9805173
    [No Abstract]   [Full Text] [Related]  

  • 37. Pneumococcal Vaccines--a Real World Perspective.
    Swaminathan S; Balajee G
    J Assoc Physicians India; 2015 Apr; 63(4 Suppl):25-8. PubMed ID: 26562960
    [No Abstract]   [Full Text] [Related]  

  • 38. An economic evaluation of thermostable vaccines in Cambodia, Ghana and Bangladesh.
    Levin A; Levin C; Kristensen D; Matthias D
    Vaccine; 2007 Sep; 25(39-40):6945-57. PubMed ID: 17707556
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Costs of diarrheal disease and the cost-effectiveness of a rotavirus vaccination program in kyrgyzstan.
    Flem ET; Latipov R; Nurmatov ZS; Xue Y; Kasymbekova KT; Rheingans RD
    J Infect Dis; 2009 Nov; 200 Suppl 1():S195-202. PubMed ID: 19817600
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Commentary: Pneumococcal immunization may not be cost-effective in the elderly in developed countries.
    Waugh N
    Int J Epidemiol; 2005 Jun; 34(3):575-6. PubMed ID: 15764693
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.